Partnership enables brands that use inkjet to forensically tag
products and packaging, test throughout the supply chain, and track
globally to certify product claims, and prevent diversion and
counterfeits
STONY BROOK, N.Y. -- (Business Wire)
Applied
DNA Sciences, Inc. (“Applied DNA,” “the company,” NASDAQ: APDN), has
entered into a strategic partnership with Videojet
Technologies (Videojet). Applied DNA and Videojet have collaborated in
the design of co-branded Applied DNA SigNature®
molecular-tagged Videojet inks, and a co-branded printer that
electronically restricts the use of ink cartridges to only those that
contain SigNature DNA inks. The relationship brings the potential to
empower the tagging of countless commercial items, all of which are
candidates for a CertainT™ licensing agreement, enabling traceability
along the entire supply chain. These solutions will be jointly
introduced this week at Pack
Expo 2017 in Las Vegas, NV.
Integrating the technologies from both companies creates a world-class
solution that will be offered to the many industries in which both
companies are already engaged. Videojet’s 325,000-install base of
printers, which code and mark well over ten billion products each day,
is a testament to the power of continuous inkjet printing (CIJ)
technology. The initial offering utilizes Videojet’s newly released 1860
printer, which will be co-branded with Applied DNA, along with
co-branded Videojet inks that will incorporate Applied DNA's unique
SigNature molecular tag into each individual ink cartridge. The
SigNature-enabled inks will be brand-specific, enabling each brand to
tag, test and track their products from source to shelf under a CertainT
platform. Gaining this additional traceability, transparency, and
ultimately trust between value chain partners will allow brands to offer
a new level of certainty to their customers that the products they are
buying are authentic.
The initial rollout of co-branded SigNature molecular tagged inks
includes an aerospace-approved ink. This durable black ink was chosen to
qualify first, due to its specific application and use in US military
and aerospace industry for unique identifier (UID) tags for an array of
critical components spanning several Federal Supply Groups (FSGs).
Initial qualification testing, confirming that the molecular tagged ink
does not impact printer uptime or operation, was performed under Applied
DNA’s first Rapid Innovation Fund (RIF) contract awarded by the Office
of the Secretary of Defense. In addition to critical FSG items, this ink
is most commonly used as a date/lot code marking solution for food,
tobacco, coffee, baby, health and personal care.
“We are very excited to team with Videojet to bring this combined
solution to market and offer a broad range of companies a definitive
method to support their brand protection strategies. This is a
significant opportunity to increase the universe of SigNature-tagged
items, increase our market share, and broadly secure the supply chains
of complex commercial ecosystems through the use of our CertainT
platform,” stated Dr. James Hayward, President and CEO of Applied DNA.
“Applied DNA’s SigNature molecular tags and CertainT platform
complements Videojet’s marking and coding solutions, allowing us to
offer a new secure ink option, adding to our robust portfolio of brand
protection and industrial track and trace offerings that are used across
many commercial industries,” said Fred Susi, Videojet VP of Business and
Product Planning.
About Videojet Technologies
Videojet Technologies is a world-leader in the product identification
market, providing in-line printing, coding, and marking products,
application specific fluids, and product life cycle services. Our goal
is to partner with our customers in the consumer packaged goods,
pharmaceutical, and industrial goods industries to improve their
productivity, to help protect and grow their brands, and to stay ahead
of industry trends and regulations. With our customer application
experts and technology leadership in continuous inkjet (CIJ), thermal
inkjet (TIJ), laser marking, thermal transfer overprinting (TTO), case
coding and labeling, and wide array printing, Videojet has more than
345,000 printers installed worldwide. Our customers rely on Videojet
products to print on over ten billion products daily. Customer sales,
application, service, and training support is provided by direct
operations with over 4,000 team members in 26 countries worldwide. In
addition, the Videojet distribution network includes more than 400
distributors and OEMs, serving 135 countries.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply
chain security, anti-counterfeiting and anti-theft technology, product
genotyping and DNA mass production for diagnostics and therapeutics.
We make life real and safe by providing innovative, molecular-based
technology solutions and services that can help protect products,
brands, entire supply chains, and intellectual property of companies,
governments and consumers from theft, counterfeiting, fraud and
diversion. The proprietary DNA-based “CertainT™” platform can be used to
identify, tag, test, and track products, to help assure authenticity,
origin, traceability, sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that
is at the heart of a family of uncopiable, security and authentication
solutions such as SigNature® T and fiberTyping®,
targeted toward textiles and apparel, BackTrac™ and DNAnet®,
for anti-theft and loss prevention, and digitalDNA®,
providing powerful track-and-trace. All provide a forensic chain of
evidence, and can be used to prosecute perpetrators. Applied DNA
Sciences is also engaged in the large-scale production of specific DNA
sequences using the polymerase chain reaction.
Visit adnas.com
for more information. Follow us on Twitter
and LinkedIn.
Join our mailing
list.
The Company’s common stock is listed on NASDAQ under the symbol APDN,
and its warrants are listed under the symbol APDNW.
Forward Looking Statements
The statements made by APDN in this press release may be
"forward-looking" in nature within the meaning of the Private Securities
Litigation Act of 1995. Forward-looking statements describe APDN's
future plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many of
which are beyond the control of APDN. Actual results could differ
materially from those projected due to our short operating history,
limited financial resources, limited market acceptance, market
competition and various other factors detailed from time to time in
APDN's SEC reports and filings, including our Annual Report on Form 10-K
filed on December 6, 2016, and our subsequent quarterly reports on Form
10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017, which
are available at www.sec.gov.
APDN, undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances after the
date hereof to reflect the occurrence of unanticipated events, unless
otherwise required by law.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170926005240/en/
Contacts:
Investor:
LHA Investor Relations
Sanjay M. Hurry,
212-838-3777
shurry@lhai.com
or
Media:
Dian
Griesel Int’l
Susan Forman, 212-825-3210
sforman@dgicomm.com
or
Program
Contact:
Janice Meraglia, 631-240-8821
janice.meraglia@adnas.com
web:
www.adnas.com
twitter:
@APDN
Source: Applied DNA Sciences, Inc.
© 2024 Canjex Publishing Ltd. All rights reserved.